First Report of Cystobasidium slooffiae in Human Wounds from China: Molecular Identification and Clinical Insights
Infection and Drug Resistance · 2025-11 · Volume 18 · 5877-5886
DOI: 10.2147/idr.s551470 ↗Kurz gefasst
Fachartikel in der Zeitschrift Infection and Drug Resistance, 2025-11. Verfasst von Jingjing Huang und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Laboratory, The Affiliated Huai'an No. 1 People's Hospital, Nanjing Medical University, Huai'an, People's Republic of China. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Background
Cystobasidium spp. are rare yeasts recently recognized as emerging human pathogens. This study presents the first report from China of Cystobasidium slooffiae isolated from human wound infections, and characterizes its microbiological profile, phylogenetic identity, and antifungal susceptibility.
Methods
Two strains were isolated from skin wounds of immunocompromised patients. They were characterized based on colony morphology on Sabouraud dextrose agar, Gram staining, MALDI-TOF MS analysis, Erg11 amino acid sequences analysis, and phylogenetic analysis using combined sequences of 18S rDNA, D1/D2 domains, and ITS regions. Antifungal susceptibility testing was performed according to CLSI guidelines (M27-A3/M60).
Results
The colonies transitioned from light yellow to orange within 48– 96 h with Gram-positive budding cells. MALDI-TOF MS failed to identify accurately any of these strains. However, phylogenetic analysis of ITS confirmed that both strains were C. slooffiae . Both strains exhibited high minimum inhibitory concentrations (MICs) for all three echinocandins (> 8 μg/mL) and fluconazole (32– 64 μg/mL), whereas the MICs for isavuconazole were in the range 0.75– 1 μg/mL. Erg11 sequence analysis revealed they formed a distinct clade that was genetically distant from Rhodotorulaceae.
Conclusion
Our findings showed that C. slooffiae could be an important emerging, opportunistic human invasive fungal pathogen because of its reduced susceptibility to echinocandins and fluconazole. Keywords: Cystobasidium slooffiae , skin wounds, superficial infections, Rhodotorula
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Clinical Laboratory, The Affiliated Huai'an No. 1 People's Hospital, Nanjing Medical University, Huai'an, People's Republic of China.
- Department of Laboratory Medicine, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People's…
- Infectious Disease Research Laboratory, National Centre for Infectious Diseases, Singapore.
- Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore.
- Faculty of Medicine, University of British Columbia, Vancouver, Canada.
ORCID-Profile: Lijing Guo, Ge Zhang, Weichen Huang, Kuo Li, Xinyi Jin, Xinfei Chen, Yingchun Xu, Ning Lin
Zitieren
APA
Huang, J., Guo, L., Zhang, G., Tsui, C. K. M., Huang, W., Li, K., Jin, X., Liu, Y., Chen, X., Tang, C., Xu, Y., & Lin, N. (2025). First Report of Cystobasidium slooffiae in Human Wounds from China: Molecular Identification and Clinical Insights. Infection and Drug Resistance, Volume 18, 5877-5886. https://doi.org/10.2147/idr.s551470
Vancouver
Huang J, Guo L, Zhang G, Tsui CKM, Huang W, Li K, et al. First Report of Cystobasidium slooffiae in Human Wounds from China: Molecular Identification and Clinical Insights. Infection and Drug Resistance. 2025;Volume 18:5877-5886. doi:10.2147/idr.s551470
BibTeX
@article{Huang2025,
author = {Huang, Jingjing and Guo, Lijing and Zhang, Ge and Tsui, Clement Kin Ming and Huang, Weichen and Li, Kuo and Jin, Xinyi and Liu, Yali and Chen, Xinfei and Tang, Chaogui and Xu, Yingchun and Lin, Ning},
title = {First Report of Cystobasidium slooffiae in Human Wounds from China: Molecular Identification and Clinical Insights},
journal = {Infection and Drug Resistance},
year = {2025},
volume = {Volume 18},
pages = {5877--5886},
doi = {10.2147/idr.s551470}
}
EUVIMED